Wednesday, May 15, 2024 · SEC filings
What the smart money revealed on May 15
618 insider filings came in. We hid 60 planned (10b5-1) sellers and 349 people whose filings were routine, like grants and tax withholding.
6 insiders at Biocryst Pharmaceuticals (BCRX) bought $857K of stock
Roles: CEO, CFO, Chief Commercial Officer, Chief Legal Officer, Chief R&D Officer, Director. Several insiders buying in the same few days is rare.
Red Rock Resorts (RRR) Vice President Lorenzo Fertitta bought $40.3M
800,000 shares on the open market. Not a grant or an option exercise.
Nextnav (NN) Director Neil Subin bought $1.14M
150,000 shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 3 checked quarters beat the typical stock 6 months later.
Warner Bros. Discovery (WBD) President Gerhard Zeiler bought $830K
100,000 shares on the open market. Not a grant or an option exercise.
Humacyte (HUMA) Director Gordon Binder bought $668K
100,000 shares on the open market. Not a grant or an option exercise.
Magnolia Oil & Gas (MGY) Director John Walker sold $307M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 4.16M shares directly.
Red Rock Resorts (RRR) CEO Frank Fertitta III sold $40.3M
Not marked as a planned 10b5-1 sale. Sold 2% of the shares they held directly. Still holds 45.85M shares.
Blend Labs (BLND) Head of Blend Nima Ghamsari sold $1.99M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 48 more real buys
Show 128 more real sales
13F season
Holdings as of Mar 31, 2024 are due May 15
50 funds have filed so far. 49 filed for the quarter before.
Biggest real insider buys, May 9–15
Open-market buys by officers and directors, filed in the 7 days up to May 15.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.